Crossmark

An updated systematic review and meta-analysis on the efficacy and safety of nivolumab/relatlimab combination therapy in melanoma patients

Published Online: 2025-05-13

Authors

Hosseini, Mohammad-Salar

Jadidi-Niaragh, Farhad
License Information

Text and Data Mining valid from 2025-05-13

Version of Record valid from 2025-05-13
More Information

Article History

Received: 19 March 2025

Revised: 21 April 2025

Accepted: 1 May 2025

First Online: 13 May 2025

Declarations

:

: The authors declare no competing interests.

Document is current